Grantham, Mayo, Van Otterloo & Co (GMO)
LH icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Labcorp LH Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12,067
Closed -$2.46M – 580
2024
Q2 		$2.46M Sell
12,067
-13,488
-53% -$2.74M 0.01% 354
2024
Q1 		$5.58M Sell
25,555
-1,873
-7% -$413K 0.02% 300
2023
Q4 		$6.23M Sell
27,428
-100,732
-79% -$21.2M 0.03% 280
2023
Q3 		$25.8M Sell
128,160
-32,978
-20% -$6.96M 0.12% 151
2023
Q2 		$33.4M Sell
161,138
-28,086
-15% -$5.45M 0.15% 118
2023
Q1 		$37.3M Sell
189,224
-30,264
-14% -$6.23M 0.19% 100
2022
Q4 		$44.4M Buy
219,488
+69,332
+46% +$13.6M 0.24% 82
2022
Q3 		$26.4M Buy
150,156
+1,979
+1% +$405K 0.15% 134
2022
Q2 		$29.8M Buy
148,177
+19,439
+15% +$4.14M 0.16% 125
2022
Q1 		$29.2M Buy
128,738
+6,052
+5% +$1.42M 0.14% 127
2021
Q4 		$33.1M Buy
122,686
+932
+0.8% +$231K 0.16% 104
2021
Q3 		$29.4M Buy
121,754
+6,440
+6% +$1.62M 0.15% 120
2021
Q2 		$27.3M Buy
115,314
+20,836
+22% +$4.75M 0.14% 130
2021
Q1 		$20.7M Buy
94,478
+43,533
+85% +$8.74M 0.11% 146
2020
Q4 		$8.91M Buy
50,945
+48,655
+2,125% +$8.4M 0.05% 212
2020
Q3 		$370K Buy
+2,290
New +$363K ﹤0.01% 668
2016
Q2 		– Sell
-4,540
Closed -$457K – 599
2016
Q1 		$457K Sell
4,540
-12,571
-73% -$1.21M ﹤0.01% 470
2015
Q4 		$1.82M Sell
17,111
-41,310
-71% -$4.26M 0.01% 342
2015
Q3 		$5.44M Sell
58,421
-19,311
-25% -$2M 0.02% 236
2015
Q2 		$8.1M Buy
77,732
+31,544
+68% +$3.28M 0.03% 210
2015
Q1 		$5M Sell
46,188
-59,946
-56% -$6.16M 0.01% 260
2014
Q4 		$9.84M Sell
106,134
-36,189
-25% -$3.2M 0.03% 191
2014
Q3 		$12.4M Sell
142,323
-106,623
-43% -$9.63M 0.03% 190
2014
Q2 		$21.9M Sell
248,946
-875,610
-78% -$75.8M 0.06% 136
2014
Q1 		$94.9M Sell
1,124,556
-173,617
-13% -$13.8M 0.25% 66
2013
Q4 		$102M Sell
1,298,173
-175,740
-12% -$15M 0.25% 63
2013
Q3 		$126M Sell
1,473,913
-708,592
-32% -$59.7M 0.33% 53
2013
Q2 		$188M Buy
+2,182,505
New +$181M 0.49% 37

Other funds holding LH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s LH Position: Q3 2024 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Labcorp (LH) in Q3 2024, closing a stake of 12,067 shares — an estimated $2.46M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in LH in Q2 2013 and held it in 28 quarters. The position peaked at $188M in Q2 2013. 918 funds tracked by Wall St. Rank hold LH as of Q3 2024.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Labcorp position as of Q3 2024 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 12,067 Labcorp shares in Q3 2024, an estimated $2.46M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Labcorp in Q2 2013 and held it in 28 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Labcorp position peaked at $188M in Q2 2013.
  • 918 funds tracked by Wall St. Rank held Labcorp as of Q3 2024.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2024, filed 13 Nov 2024.